GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ProSomnus Inc (OTCPK:OSAPQ) » Definitions » Beneish M-Score

ProSomnus (ProSomnus) Beneish M-Score : -3.38 (As of May. 27, 2024)


View and export this data going back to 2022. Start your Free Trial

What is ProSomnus Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.38 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for ProSomnus's Beneish M-Score or its related term are showing as below:

OSAPQ' s Beneish M-Score Range Over the Past 10 Years
Min: -4.2   Med: -3.99   Max: -3.38
Current: -3.38

During the past 4 years, the highest Beneish M-Score of ProSomnus was -3.38. The lowest was -4.20. And the median was -3.99.


ProSomnus Beneish M-Score Historical Data

The historical data trend for ProSomnus's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProSomnus Beneish M-Score Chart

ProSomnus Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - - -4.20

ProSomnus Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -4.06 -3.91 -4.20 -3.38

Competitive Comparison of ProSomnus's Beneish M-Score

For the Medical Devices subindustry, ProSomnus's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProSomnus's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ProSomnus's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where ProSomnus's Beneish M-Score falls into.



ProSomnus Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of ProSomnus for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1932+0.528 * 1.0443+0.404 * 2.1801+0.892 * 1.3655+0.115 * 0.6431
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9074+4.679 * -0.377989-0.327 * 1.3369
=-3.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was $4.34 Mil.
Revenue was 7.458 + 7.838 + 7.071 + 6.934 = $29.30 Mil.
Gross Profit was 3.625 + 3.705 + 3.491 + 3.763 = $14.58 Mil.
Total Current Assets was $11.65 Mil.
Total Assets was $23.88 Mil.
Property, Plant and Equipment(Net PPE) was $11.75 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.07 Mil.
Selling, General, & Admin. Expense(SGA) was $26.60 Mil.
Total Current Liabilities was $38.96 Mil.
Long-Term Debt & Capital Lease Obligation was $7.50 Mil.
Net Income was 3.441 + -6.869 + -11.239 + 0.905 = $-13.76 Mil.
Non Operating Income was 6.378 + 2.095 + -5.533 + 7.881 = $10.82 Mil.
Cash Flow from Operations was -2.522 + -5.811 + -2.527 + -4.697 = $-15.56 Mil.
Total Receivables was $2.66 Mil.
Revenue was 5.808 + 5.792 + 4.998 + 4.86 = $21.46 Mil.
Gross Profit was 3.052 + 3.105 + 2.458 + 2.538 = $11.15 Mil.
Total Current Assets was $16.55 Mil.
Total Assets was $28.59 Mil.
Property, Plant and Equipment(Net PPE) was $11.77 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.67 Mil.
Selling, General, & Admin. Expense(SGA) was $21.47 Mil.
Total Current Liabilities was $7.50 Mil.
Long-Term Debt & Capital Lease Obligation was $34.10 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(4.339 / 29.301) / (2.663 / 21.458)
=0.148084 / 0.124103
=1.1932

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(11.153 / 21.458) / (14.584 / 29.301)
=0.51976 / 0.49773
=1.0443

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (11.65 + 11.75) / 23.879) / (1 - (16.552 + 11.77) / 28.585)
=0.020059 / 0.009201
=2.1801

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=29.301 / 21.458
=1.3655

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.67 / (0.67 + 11.77)) / (1.074 / (1.074 + 11.75))
=0.053859 / 0.083749
=0.6431

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(26.599 / 29.301) / (21.466 / 21.458)
=0.907785 / 1.000373
=0.9074

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((7.503 + 38.957) / 23.879) / ((34.1 + 7.502) / 28.585)
=1.945643 / 1.455379
=1.3369

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-13.762 - 10.821 - -15.557) / 23.879
=-0.377989

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

ProSomnus has a M-score of -3.38 suggests that the company is unlikely to be a manipulator.


ProSomnus Beneish M-Score Related Terms

Thank you for viewing the detailed overview of ProSomnus's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


ProSomnus (ProSomnus) Business Description

Traded in Other Exchanges
N/A
Address
5675 Gibraltar Drive, Pleasanton, CA, USA, 94588
ProSomnus Inc is a medical device manufacturer. It manufacturers precision, mass-customized oral appliance therapy devices to treat obstructive sleep apnea, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus's patented devices are more comfortable and less invasive alternative to continuous positive airway pressure therapy, and lead to more effective and patient-preferred outcomes.
Executives
Sung Kim officer: Chief Technical Officer 5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
John Steffens 10 percent owner C/O DIGITALBRIDGE GROUP, INC., 750 PARK OF COMMERCE DRIVE SUITE 210, BOCCA RATON FL 33487
Gregory P. Ho 10 percent owner C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Brian B Dow officer: Chief Financial Officer 5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Smc Holdings Ii, Lp 10 percent owner 65 EAST 55TH STREET, 33RD FLOOR, NEW YORK NY 10022
Smc Holdings Ii G.p., Llc 10 percent owner C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Laing Rikkers director 5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Len Liptak director, officer: Chief Executive Officer 5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Mark Thomas Murphy officer: Chief Growth Officer 5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Hgp Iii, Llc 10 percent owner 3708 ASHFORD PLACE, GREENVILLE NC 27858
Steven Robert Pacelli director 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Hmc, Llc 10 percent owner 3708 ASHFORD PLACE, GREENVILLE NC 27858
Healthpointcapital, Llc 10 percent owner C/O HEALTHPOINTCAPITAL, 505 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
Healthpointcapital Partners Iii Lp 10 percent owner 505 Park Avenue, 12th Floor, New York NY 10022
Leonard Hedge director 7855 BELLA MONTANIA LANE, PALO CEDRO CA 96073